hydronidone: Clinical Trials

13 trials of hydronidone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 recruiting, 1 not yet recruiting. 6 Phase 1, 4 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 16Completed 5, Recruiting 1
Phase 34Completed 2, Not yet recruiting 1, Recruiting 1
Phase 23Completed 3

Follow hydronidone: new trials by email Literature Review of hydronidone trials Research Report on hydronidone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Hydronidone Capsules in Patients With Chronic Hepatitis B Virus-Related Liver Fibrosis
Hydronidone capsules - Chronic Hepatitis B-related Liver Fibrosis
Phase 2CompletedBeijing Continent Pharmaceutical Co, Ltd.672026-04-152026-08-13
Study of Hydroxynidone Capsules in Patients With Hepatic Impairment and Matched Healthy Controls
Hydronidone capsules - Liver Fibrosis
Phase 1CompletedBeijing Continent Pharmaceutical Co, Ltd.302026-03-252026-08-13
A Clinical Trial Evaluating the Safety of Hydronidone Capsules in Patients With Hepatic Fibrosis and Liver Cirrhosis
Hydronidone Capsules - Chronic Hepatitis B With Hepatic Fibrosis
Phase 3CompletedBeijing Continent Pharmaceutical Co, Ltd.3372026-03-162026-08-13
A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis
Hydronidone capsules - Chronic Hepatitis B With Hepatic Fibrosis
Phase 2CompletedBeijing Continent Pharmaceutical Co, Ltd.4112026-03-122026-08-13
A Phase IIIc Clinical Study to Evaluate the Long-term Treatment of Hydronidone Capsules for Liver Fibrosis in Patients With Chronic Hepatitis B.
Hydronidone (270mg), Hydronidone (Placebo Group) - Liver Fibrosis, Liver Fibrosis in Chronic Hepatitis B
Phase 3Not yet recruitingBeijing Continent Pharmaceutical Co, Ltd.12082026-01-302026-02-17
QTc Assessment in a Single-Dose Study of Hydronidone Capsules
Hydronidone, Placebo - Hepatic Fibrosis
Phase 1CompletedBeijing Continent Pharmaceutical Co, Ltd.482025-12-302026-08-13
A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency
Hydronidone capsules - Renal Insufficiency Chronic
Phase 1RecruitingBeijing Continent Pharmaceutical Co, Ltd.562025-12-252026-08-13
The Phase Ⅰd Clinical Trial of Hydronidone Capsules
Hydronidone capsules, Placebo capsules - Liver Fibrosis
Phase 1CompletedBeijing Continent Pharmaceutical Co, Ltd.1382025-12-242026-09-21
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Hydronidone capsules, The placebo capsules - Liver Fibrosis
Phase 3RecruitingBeijing Continent Pharmaceutical Co, Ltd.2482023-08-122025-06-04
Hydronidone for the Treatment of Liver Fibrosis Associated with Chronic Viral Hepatitis B Phase 3 Trial.
Hydronidone capsules, The placebo capsules - Liver Fibrosis
Phase 3CompletedBeijing Continent Pharmaceutical Co, Ltd.2482021-12-302024-12-20
Study on Pharmacokinetics of Hydronidone
Hydronidone - Pharmacokinetics of Hydronidone
Phase 1CompletedBeijing Continent Pharmaceutical Co, Ltd.482019-10-302021-03-24
Study on PK of Hydronidone in Patients and Special Population
Hydronidone - Hepatitis b & Liver Dysfunction
Phase 1CompletedBeijing Continent Pharmaceutical Co, Ltd.82019-09-032021-03-24
A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis
Hydronidone, Placebo, Entecavir - Hepatitis B, Chronic
Phase 2CompletedShanghai Genomics, Inc.1682015-06-252022-06-23

Conditions studied

Liver Cirrhosis (6)  ·  Hepatitis B (1)  ·  Hepatitis B, Chronic (1)  ·  Liver Diseases (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Beijing Continent Pharmaceutical Co, Ltd. (12)  ·  Shanghai Genomics, Inc. (1)

Countries

China (13)

Top investigators

Jun Cheng (1)  ·  Jun Cheng, Dr (1)  ·  Jun Cheng, Dr. (1)  ·  LunGen Lu (1)  ·  Lungen Lu, Dr (1)  ·  Lungen Lu, Dr. (1)

Results publications

PMID 35842120